1. Home
  2. EFSI vs TNXP Comparison

EFSI vs TNXP Comparison

Compare EFSI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFSI
  • TNXP
  • Stock Information
  • Founded
  • EFSI 1881
  • TNXP 2007
  • Country
  • EFSI United States
  • TNXP United States
  • Employees
  • EFSI N/A
  • TNXP N/A
  • Industry
  • EFSI Major Banks
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFSI Finance
  • TNXP Health Care
  • Exchange
  • EFSI Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • EFSI 193.5M
  • TNXP 197.9M
  • IPO Year
  • EFSI N/A
  • TNXP N/A
  • Fundamental
  • Price
  • EFSI $37.00
  • TNXP $15.12
  • Analyst Decision
  • EFSI Strong Buy
  • TNXP Buy
  • Analyst Count
  • EFSI 2
  • TNXP 1
  • Target Price
  • EFSI $39.50
  • TNXP $70.00
  • AVG Volume (30 Days)
  • EFSI 8.5K
  • TNXP 778.7K
  • Earning Date
  • EFSI 10-23-2025
  • TNXP 11-10-2025
  • Dividend Yield
  • EFSI 3.37%
  • TNXP N/A
  • EPS Growth
  • EFSI N/A
  • TNXP N/A
  • EPS
  • EFSI 2.13
  • TNXP N/A
  • Revenue
  • EFSI $66,122,000.00
  • TNXP $10,299,000.00
  • Revenue This Year
  • EFSI N/A
  • TNXP $14.79
  • Revenue Next Year
  • EFSI $27.28
  • TNXP $933.49
  • P/E Ratio
  • EFSI $17.27
  • TNXP N/A
  • Revenue Growth
  • EFSI 3.18
  • TNXP N/A
  • 52 Week Low
  • EFSI $28.70
  • TNXP $6.76
  • 52 Week High
  • EFSI $40.03
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • EFSI 57.27
  • TNXP 35.51
  • Support Level
  • EFSI $34.63
  • TNXP $13.70
  • Resistance Level
  • EFSI $36.49
  • TNXP $18.25
  • Average True Range (ATR)
  • EFSI 0.53
  • TNXP 1.28
  • MACD
  • EFSI 0.17
  • TNXP 0.07
  • Stochastic Oscillator
  • EFSI 88.24
  • TNXP 26.08

About EFSI Eagle Financial Services Inc Common Stock

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: